NM_001845.6:c.2194-69C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.2194-69C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.124 in 1,605,950 control chromosomes in the GnomAD database, including 13,455 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.095 ( 888 hom., cov: 33)
Exomes 𝑓: 0.13 ( 12567 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.43

Publications

8 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 13-110179490-G-A is Benign according to our data. Variant chr13-110179490-G-A is described in ClinVar as [Benign]. Clinvar id is 1293381.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.141 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A1NM_001845.6 linkc.2194-69C>T intron_variant Intron 29 of 51 ENST00000375820.10 NP_001836.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A1ENST00000375820.10 linkc.2194-69C>T intron_variant Intron 29 of 51 1 NM_001845.6 ENSP00000364979.4 P02462-1

Frequencies

GnomAD3 genomes
AF:
0.0949
AC:
14441
AN:
152116
Hom.:
888
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0279
Gnomad AMI
AF:
0.144
Gnomad AMR
AF:
0.0961
Gnomad ASJ
AF:
0.120
Gnomad EAS
AF:
0.00462
Gnomad SAS
AF:
0.150
Gnomad FIN
AF:
0.125
Gnomad MID
AF:
0.117
Gnomad NFE
AF:
0.131
Gnomad OTH
AF:
0.105
GnomAD4 exome
AF:
0.127
AC:
184849
AN:
1453716
Hom.:
12567
AF XY:
0.129
AC XY:
93328
AN XY:
723824
show subpopulations
African (AFR)
AF:
0.0235
AC:
782
AN:
33334
American (AMR)
AF:
0.0722
AC:
3225
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
0.111
AC:
2889
AN:
26078
East Asian (EAS)
AF:
0.00767
AC:
304
AN:
39644
South Asian (SAS)
AF:
0.154
AC:
13246
AN:
86078
European-Finnish (FIN)
AF:
0.127
AC:
6679
AN:
52654
Middle Eastern (MID)
AF:
0.0718
AC:
413
AN:
5756
European-Non Finnish (NFE)
AF:
0.136
AC:
150037
AN:
1105398
Other (OTH)
AF:
0.121
AC:
7274
AN:
60106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
8711
17421
26132
34842
43553
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5352
10704
16056
21408
26760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0948
AC:
14437
AN:
152234
Hom.:
888
Cov.:
33
AF XY:
0.0942
AC XY:
7010
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.0279
AC:
1157
AN:
41540
American (AMR)
AF:
0.0959
AC:
1467
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.120
AC:
415
AN:
3470
East Asian (EAS)
AF:
0.00463
AC:
24
AN:
5184
South Asian (SAS)
AF:
0.150
AC:
724
AN:
4824
European-Finnish (FIN)
AF:
0.125
AC:
1328
AN:
10592
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.131
AC:
8937
AN:
68014
Other (OTH)
AF:
0.105
AC:
223
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
680
1360
2040
2720
3400
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.114
Hom.:
2247
Bravo
AF:
0.0874
Asia WGS
AF:
0.0720
AC:
249
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.060
DANN
Benign
0.64
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2131939; hg19: chr13-110831837; API